Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Aiping Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1632-837X; OpenAlex author ID A5101509068. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

  1. A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer. Co-author DOI 10.12659/msm.927654↗
  2. Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. Last author DOI 10.1007/s00280-018-3650-4↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wen Zhang · 2 shared papers, 2018–2020 · strength 0.19
  2. Hanzhi Cui · 1 shared paper, 2020 · strength 0.11
  3. Jun Zhou · 1 shared paper, 2020 · strength 0.11
  4. Guochao Deng · 1 shared paper, 2020 · strength 0.11
  5. Changjie Lou · 1 shared paper, 2020 · strength 0.11
  6. Yanqiao Zhang · 1 shared paper, 2020 · strength 0.11
  7. Guanghai Dai · 1 shared paper, 2020 · strength 0.11
  8. Yongkun Sun · 1 shared paper, 2018 · strength 0.08
  9. Chengfeng Wang · 1 shared paper, 2018 · strength 0.08
  10. Chunxia Du · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.